A 60-Year-Old Man Presents With Plantar Hyperkeratosis & Erythema

Poll

A 60-year-old man presents with localized tender plaques of hyperkeratosis and a surrounding erythematous halo on the weight-bearing plantar aspect of his feet after beginning cancer treatment. Which medication is responsible for this cutaneous presentation and what is the name of this reaction?

A 60-year-old man presents with localized tender plaques of hyperkeratosis and a surrounding erythematous halo on the weight-bearing plantar aspect of his feet after beginning cancer treatment.

What is your diagnosis?

A. Capecitabine, hand-foot skin reaction
B. Capecitabine, hand-foot syndrome
C. Regorafenib, hand-foot syndrome
D. Regorafenib, hand-foot skin reaction
Recent Videos
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
3 experts in this video
5 experts in this video
5 experts in this video
Related Content
Durvalumab Is Not Statistically Significant Vs Cetuximab in HNSCC

Durvalumab Is Not Statistically Significant Vs Cetuximab in HNSCC

Ariana Pelosci
March 13th 2025
Article

The trial was terminated early due to no statistical significance observed between durvalumab and cetuximab for patients with head and neck squamous cell carcinoma.

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Oncologists Reflect on Pandemic's Lasting Impact on Cancer Care

Aditya Bardia, MD, MPH;Ritu Salani, MD;Scarlett Lin Gomez, PhD;Marwan G. Fakih, MD;Elizabeth Ren Zhang-Velten, MD, PhD;Frances Chow, MD;James B. Yu, MD, MHS, FASTRO
March 10th 2025
Podcast

Hear from leading cancer experts about the lasting impact the COVID-19 pandemic has left on clinical practice.

The 2025 SGO meeting will feature readouts of potentially impactful trial data in ovarian cancer, cervical cancer, and other gynecologic malignancies.

A Glimpse at Practice-Shifting Presentations at The 2025 SGO Annual Meeting

Russ Conroy
March 13th 2025
Article

The 2025 SGO meeting will feature readouts of potentially impactful trial data in ovarian cancer, cervical cancer, and other gynecologic malignancies.

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;Stephanie A. Berg, DO
March 7th 2025
Podcast

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Five-Year Impact of the COVID-19 Pandemic on the Oncology Community

Five-Year Impact of the COVID-19 Pandemic on the Oncology Community

ONCOLOGY Staff
March 13th 2025
Article

Leading multidisciplinary oncology professionals look back at how the COVID-19 pandemic changed cancer care.

Retrospective data may offer actionable guidance for clinicians treating patients with non–small cell lung cancer and brain metastases.

Immunotherapy/Radiation Shows Responses in NSCLC Brain Metastases

Russ Conroy
March 12th 2025
Article

Retrospective data may offer actionable guidance for clinicians treating patients with non–small cell lung cancer and brain metastases.